Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Febantel; Pyrantel embonate ; Praziquantel
Bayer Animal Health GmbH
QP52AA51
Febantel; Pyrantel embonate ; Praziquantel
525,504,175 mg/tablet
Tablet
CAM: Companion Animal Medicine as defined in relevant national legislation
praziquantel, combinations
Authorised
2017-09-08
Health Products Regulatory Authority 22 June 2020 CRN009RGL Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Bayer Dog Tasty Bone XL 525/504/175 mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCES 525 mg febantel 175 mg pyrantel equivalent to 504 mg pyrantel embonate 175 mg praziquantel EXCIPIENTS For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. A light-brown to brown, meat flavoured, bone shaped tablet scored on both sides that can be divided into halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of mixed infections by nematodes andcestodes of the following species: Roundworms: Ascarids (adult and late immatureforms): _Toxocara canis, Toxascaris leonina_ Hookworms(adults): _Uncinaria stenocephala, Ancylostoma caninum_ Whipworms(adults): _Trichuris vulpis_ Tapeworms (adult and immatureforms): _Echinococcus granulosus_ _Echinococcus multilocularis_ _Dipylidium caninum_ _Taenia spp._ 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substances or to any of the excipients. Do not use during the 1st and 2nd trimester of pregnancy (see section 4.7). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Fleas serve as intermediate hosts for one common type of tapeworm - _Dipylidium caninum_. Tapeworm infestation is certain to re-occur unless control of intermediate hosts such as fleas, mice etc. is undertaken. Health Products Regulatory Authority 22 June 2020 CRN009RGL Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class. To minimise the risk of reinfestation and new infestation, excreta should be collected and properly disposed of for 24 hours following treatment. Special precautions to be tak Read the complete document